About
Xsphera Biosciences envisions a world where failure is no longer the most likely outcome in oncology clinical trials. Our ex vivo platform, invented at the Dana-Farber Cancer Institute, is a powerful integration of biology and cloud computing that accelerates drug development. Xsphera uniquely enables the study of single-variable testing, which is not possible with in vivo studies.
Human Tissue Predicts Human Response
Drug testing is dominated by in vivo tests of engineered mice - which are notoriously poor predictors of drug performance. Xsphera believes human tissue is the best predictor of human response. High quality, human tissue samples are sourced from our clinical network. Xsphera then captures the entirety of each patient’s tumor microenvironment in microfluidic devices. Each channel is treated with different therapeutics and multiple endpoints are measured including immune stimulation and tumor cell death.
Unlock the Mysteries of Drug Mechanisms
Xsphera unlocks the mysteries of drug mechanisms with our cloud platform that integrates complex multi-omic response data for each patient into a unified, intelligent interface. This accelerates scientific understanding of why patients respond to or resist therapies. Improved understanding leads to reduced clinical failure rates. With Xsphera, novel therapeutics move into the clinic with confidence.
Turn Overwhelming Data into Rapid Understanding
Drug developers are confronted with vast amounts of overwhelming and scattered data as they attempt to extract scientific understanding from study analytics. As a result, unquantifiable volumes of valuable study data sit un-analyzed on hard drives. With Xsphera, no data is left behind. Our cloud-based platform ingests and integrates tissue, patient and results data into a single unified source. AI-driven algorithms automate deep analysis and put previously unknowable insights within reach.
Company Details
- Employees
- 17
- Founded
- -
- Address
- 26 Landsdowne St, Cambridge,massachusetts 02139,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.xspherabio.com
- HQ
- Cambridge, Massachusetts
Xsphera Biosciences Inc Questions
Xsphera Biosciences Inc's website is http://www.xspherabio.com
Xsphera Biosciences Inc's LinkedIn profile is https://www.linkedin.com/company/xsphera-biosciences
Xsphera Biosciences Inc has
17 employees.
View email and phone details for 17
employees at Xsphera Biosciences Inc.
Xsphera Biosciences Inc's industry is
Biotechnology Research
Xsphera Biosciences Inc's top competitors are
Verne Bio,
Bridge Informatics,
Relay Therapeutics,
Smartlabs,
Tango Therapeutics,
Medzown,
Tessera Therapeutics,
Zwitterco,
Sanofi,
Drumroll Ai.
Xsphera Biosciences Inc's categories are Biotechnology Research
Xsphera Biosciences Inc's founding year is 2018
